279 related articles for article (PubMed ID: 16911852)
21. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
22. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
23. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
25. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
Sanderson KM; Rouprêt M
BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
[TBL] [Abstract][Full Text] [Related]
26. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
27. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
[TBL] [Abstract][Full Text] [Related]
28. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
Ishikawa S; Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Kubota K; Matsuno Y; Osawa T; Shinno Y; Kumagai A; Togashi M; Matsuda H; Mori T; Nonomura K
J Urol; 2010 Sep; 184(3):883-7. PubMed ID: 20643446
[TBL] [Abstract][Full Text] [Related]
29. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
30. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
Rogers A; Ng JK; Glendinning J; Rix D
BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
[TBL] [Abstract][Full Text] [Related]
31. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
32. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
34. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.
Jabbour ME; Desgrandchamps F; Cazin S; Teillac P; Le Duc A; Smith AD
J Urol; 2000 Apr; 163(4):1105-7; quiz 1295. PubMed ID: 10737475
[TBL] [Abstract][Full Text] [Related]
36. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H
J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma--China Medical University Hospital experience.
Chen CH; Wu HC; Chen WC; Yeh CC; Chen CC; Chang CH
Urology; 2005 Apr; 65(4):687-91. PubMed ID: 15833509
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
